Literature DB >> 7693969

Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus.

M Matloubian1, S R Kolhekar, T Somasundaram, R Ahmed.   

Abstract

This study documents that the immunosuppressive lymphocytic choriomeningitis virus (LCMV) variant, clone 13, shows a specific predilection for enhanced infection of macrophages both in vitro and in vivo and that single amino acid changes in the viral polymerase and glycoprotein are responsible for macrophage tropism. The growth difference seen between variant clone 13 and the parental Armstrong strain was specific for macrophages, since both clone 13 and Armstrong grew equally well in fibroblasts and neither isolate infected lymphocytes efficiently. Complete sequencing of the clone 13 genome, along with genetic analysis, showed that a single amino acid change in the polymerase (K-->Q at position 1079) was the major determinant of virus yield in macrophages. This was proven unequivocally by comparing the sequences of parental and reassortant viruses, which were identical at all loci except for the single mutation in the polymerase gene. This finding was further strengthened by showing that reversion at this site back to lysine (Q-->K) resulted in loss of macrophage tropism. In addition, an independently derived macrophage-tropic variant of LCMV, clone 28b, had a K-->N mutation at the same position. Thus, these results show that substitution of the positively charged amino acid K with a neutral amino acid (either Q or N) at residue 1079 of the polymerase resulted in enhanced viral replication in macrophages. In addition to the polymerase change, a mutation in the glycoprotein was also associated with macrophage tropism. This single amino acid change in the glycoprotein (F-->L at position 260) did not affect virus yield per macrophage but was critical in determining the number of macrophages infected. Our previous studies have shown that the same two mutations in the polymerase and glycoprotein are essential for establishing a chronic infection in adult mice. Since the same mutations confer macrophage tropism and ability to persist in vivo, these studies provide compelling evidence that infection of macrophages is a critical determinant of viral persistence and immune suppression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693969      PMCID: PMC238198     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Molecular basis of organ-specific selection of viral variants during chronic infection.

Authors:  R Ahmed; C S Hahn; T Somasundaram; L Villarete; M Matloubian; J H Strauss
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus.

Authors:  M S Salvato; K J Schweighofer; J Burns; E M Shimomaye
Journal:  Virus Res       Date:  1992-03       Impact factor: 3.303

3.  The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism.

Authors:  A J Cann; M J Churcher; M Boyd; W O'Brien; J Q Zhao; J Zack; I S Chen
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain.

Authors:  W A O'Brien; Y Koyanagi; A Namazie; J Q Zhao; A Diagne; K Idler; J A Zack; I S Chen
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Effective clearance of a persistent viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific bone marrow-derived cells.

Authors:  B D Jamieson; L D Butler; R Ahmed
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection.

Authors:  C C King; R de Fries; S R Kolhekar; R Ahmed
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice.

Authors:  M Matloubian; T Somasundaram; S R Kolhekar; R Selvakumar; R Ahmed
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

9.  The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies.

Authors:  J P Metlay; M D Witmer-Pack; R Agger; M T Crowley; D Lawless; R M Steinman
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.

Authors:  P Borrow; A Tishon; M B Oldstone
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

View more
  105 in total

1.  Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus.

Authors:  H Miletic; M Bruns; K Tsiakas; B Vogt; R Rezai; C Baum; K Kühlke; F L Cosset; W Ostertag; H Lother; D von Laer
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 2.  T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus.

Authors:  Aaruni Khanolkar; Michael J Fuller; Allan J Zajac
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Lymphocytic choriomeningitis virus persistence promotes effector-like memory differentiation and enhances mucosal T cell distribution.

Authors:  Lalit K Beura; Kristin G Anderson; Jason M Schenkel; Jeremiah J Locquiao; Kathryn A Fraser; Vaiva Vezys; Marion Pepper; David Masopust
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

4.  Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence.

Authors:  Brian M Sullivan; Sébastien F Emonet; Megan J Welch; Andrew M Lee; Kevin P Campbell; Juan C de la Torre; Michael B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-26       Impact factor: 11.205

5.  Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity.

Authors:  A Grande-Pérez; S Sierra; M G Castro; E Domingo; P R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-05       Impact factor: 11.205

Review 6.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

7.  Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression.

Authors:  Andreas Bergthaler; Lukas Flatz; Ahmed N Hegazy; Susan Johnson; Edit Horvath; Max Löhning; Daniel D Pinschewer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

8.  Genomic analysis and pathogenic characteristics of lymphocytic choriomeningitis virus strains isolated in Japan.

Authors:  Toshikazu Takagi; Makiko Ohsawa; Chiharu Morita; Hiroshi Sato; Kazutaka Ohsawa
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

9.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection.

Authors:  Scott N Mueller; Mehrdad Matloubian; Daniel M Clemens; Arlene H Sharpe; Gordon J Freeman; Shivaprakash Gangappa; Christian P Larsen; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.